أعرض في EDS

The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)

التفاصيل البيبلوغرافية
العنوان: The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
المؤلفون: E. Gez, Gedske Daugaard, Karim Fizazi, Charles J. Ryan, Simon Chowdhury, Raymond S. McDermott, J.M. Piulats Rodriguez, Simon Paul Watkins, F. Joly Lobbedez, J.A. Arranz Arija, Srikala S. Sridhar, Wassim Abida, Axel S. Merseburger, Brieuc Sautois, Anthony A. Golsorkhi, Axel Heidenreich, Andrew Simmons, Cora N. Sternberg, S. Shetty, Howard I. Scher
المصدر: Annals of Oncology. 28:v291
بيانات النشر: Elsevier BV, 2017.
سنة النشر: 2017
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Hematology, Castration resistant, medicine.disease, Clinical trial, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 030104 developmental biology, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Internal medicine, PARP inhibitor, Medicine, In patient, Rucaparib, business, Homologous Recombination Deficiency
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8e7121dc7d6d66e20cc2425f9c34fc4e
https://doi.org/10.1093/annonc/mdx370.053
حقوق: OPEN
رقم الأكسشن: edsair.doi...........8e7121dc7d6d66e20cc2425f9c34fc4e
قاعدة البيانات: OpenAIRE
الوصف
تدمد:09237534